Cytomegalovirus Antibody Laboratories manufactures the cmv igb reagents distributed by Genprice. The Cmv Igb reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact cytomegalovirus Antibody. Other Cmv products are available in stock. Specificity: Cmv Category: Igb
CMV Control lentiviral particles (Neo) in PBS |
|||
| CMV-Null-Neo-PBS | GenTarget | 1 x108 IFU/ml x 200ul | EUR 852 |
|
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the Neomycin marker under RSV promoter. The virus was concentrated and provided in PBS solution. |
|||
CMV Control lentiviral particles (Puro) in PBS |
|||
| CMV-Null-Puro-PBS | GenTarget | 1 x108 IFU/ml x 200ul | EUR 852 |
|
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the Puromycin marker under RSV promoter. The virus was concentrated and provided in PBS solution. |
|||
CMV Control lentiviral particles (GFP-Bsd) in PBS |
|||
| CMV-Null-GB-PBS | GenTarget | 1 x108 IFU/ml x 200ul | EUR 852 |
|
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the GFP-Blasticidin fusion marker under RSV promoter. The virus was concentrated and provided in PBS solution. |
|||
CMV Control lentiviral particles (GFP-Puro) in PBS |
|||
| CMV-Null-GP-PBS | GenTarget | 1 x108 IFU/ml x 200ul | EUR 852 |
|
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the GFP-Puromycin fusion marker under RSV promoter. The virus was concentrated and provided in PBS solution. |
|||
CMV Control lentiviral particles (RFP-Bsd) in PBS |
|||
| CMV-Null-RB-PBS | GenTarget | 1 x108 IFU/ml x 200ul | EUR 852 |
|
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the RFP-Blasticidin fusion marker under RSV promoter. The virus was concentrated and provided in PBS solution. |
|||
CMV Control lentiviral particles (RFP-Puro) in PBS |
|||
| CMV-Null-RP-PBS | GenTarget | 1 x108 IFU/ml x 200ul | EUR 852 |
|
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the RFP-Puromycin fusion marker under RSV promoter. The virus was concentrated and provided in PBS solution. |
|||
CD79b (B-Cell Marker) (IGB/1844) Antibody |
|||
| BNC041844-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD79b (B-Cell Marker) (IGB/1844), CF405S conjugate, Concentration: 0.1mg/mL |
|||
CD79b (B-Cell Marker) (IGB/1844) Antibody |
|||
| BNC041844-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD79b (B-Cell Marker) (IGB/1844), CF405S conjugate, Concentration: 0.1mg/mL |
|||
CD79b (B-Cell Marker) (IGB/1844) Antibody |
|||
| BNCAP1844-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD79b (B-Cell Marker) (IGB/1844), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
CD79b (B-Cell Marker) (IGB/1844) Antibody |
|||
| BNCAP1844-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD79b (B-Cell Marker) (IGB/1844), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
CD79b (B-Cell Marker) (IGB/1844) Antibody |
|||
| BNCH1844-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD79b (B-Cell Marker) (IGB/1844), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
CD79b (B-Cell Marker) (IGB/1844) Antibody |
|||
| BNCH1844-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD79b (B-Cell Marker) (IGB/1844), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
CD79b (B-Cell Marker) (IGB/1844) Antibody |
|||
| BNCP1844-250 | Biotium | 250uL | EUR 472.8 |
|
Description: Primary antibody against CD79b (B-Cell Marker) (IGB/1844), PerCP conjugate, Concentration: 0.1mg/mL |
|||
CD79b (B-Cell Marker) (IGB/1844) Antibody |
|||
| BNCR1844-250 | Biotium | 250uL | EUR 472.8 |
|
Description: Primary antibody against CD79b (B-Cell Marker) (IGB/1844), RPE conjugate, Concentration: 0.1mg/mL |
|||
CD79b (B-Cell Marker) (IGB/1844) Antibody |
|||
| BNC941844-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD79b (B-Cell Marker) (IGB/1844), CF594 conjugate, Concentration: 0.1mg/mL |
|||
CD79b (B-Cell Marker) (IGB/1844) Antibody |
|||
| BNC941844-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD79b (B-Cell Marker) (IGB/1844), CF594 conjugate, Concentration: 0.1mg/mL |
|||
CD79b (B-Cell Marker) (IGB/1844) Antibody |
|||
| BNCA1844-250 | Biotium | 250uL | EUR 472.8 |
|
Description: Primary antibody against CD79b (B-Cell Marker) (IGB/1844), APC conjugate, Concentration: 0.1mg/mL |
|||